Canine Mammary Tumors and Comparative Oncology

Canine mammary tumours are among the most common spontaneous cancers in intact female dogs and share striking clinicopathological, molecular and histological parallels with human breast cancer. These naturally occurring malignancies display heterogeneous histological subtypes, hormone receptor profiles and genetic alterations that mirror those in human tumours, including mutations in TP53, PIK3CA and key cell-cycle regulators. The canine immune microenvironment and tumour progression kinetics further resemble human disease, offering a unique window on tumour–host interactions. Comparative oncology leverages these similarities to accelerate biomarker discovery, refine prognostic criteria and evaluate novel therapies in a setting with intact immunity and compressed timelines. Integrating advanced imaging, genomics, immunoprofiling and digital pathology across species catalyses a ‘One Health’ approach, whereby insights from companion animals inform human oncology and vice versa. Global collaboration in veterinary and medical research is fostering translational pipelines that exploit canine models to de-risk early-stage drug development, optimise clinical trial design and ultimately improve outcomes for both dogs and people.

Research from Nature Portfolio

A pan-species digital pathology atlas has been developed using supervised deep-learning on human samples and applied to a range of vertebrates, including canine tumours. This artificial intelligence framework achieved high accuracy in classifying single-cell immune components within canine mammary tissues and established a spatial immune score linked to prognosis. A novel metric, morphospace overlap, quantifies morphological conservation across species and guides veterinary pathologists in deploying AI tools on new sample sets. These advances lay the groundwork for scalable, cross-species computational pathology platforms that promise rapid, standardised assessment of tumour phenotype and immune contexture in veterinary oncology and comparative cancer research.

Canine Mammary Tumors and Comparative Oncology publication trend

The graph below shows the total number of articles in canine mammary tumors and comparative oncology across all publications each year (not limited to Nature Index journals).

Technical terms

Comparative oncology: A discipline that studies naturally occurring cancers in animals to inform human cancer research and drug development.

Spatial immune score: A quantitative measure of immune cell distribution within tumour tissue, used to predict prognosis.

Morphospace overlap: A computational metric assessing morphological similarity of tumours across species to facilitate digital pathology transfer.

Neoadjuvant therapy: Treatment administered before the primary intervention (e.g., surgery) to shrink a tumour.

Genomic alteration: Any change in DNA sequence or copy number that may drive tumour behaviour and influence treatment response.

Immune infiltration: The presence and density of immune cells within the tumour microenvironment, reflecting antitumour activity.

PAN-species atlas: A curated digital repository of histological and molecular data spanning multiple species for comparative pathology studies.

References

1. Bridging clinic and wildlife care with AI-powered pan-species computational pathology. Nature Communications (2023).
2. Comparative oncology: overcoming human cancer through companion animal studies. Experimental & Molecular Medicine (2023).
3. Analyses of canine cancer mutations and treatment outcomes using real-world clinico-genomics data of 2119 dogs. npj Precision Oncology (2023).
4. Neoadjuvant Intratumoral Immunotherapy with Cowpea Mosaic Virus Induces Local and Systemic Antitumor Efficacy in Canine Mammary Cancer Patients. Cells (2023).